#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4048221	ADME	Drug level in human liver microsomes treated with (R)-2-methyl-N1-((S)-11-oxo-1,2,3,5,10,11-hexahydrobenzo[d]pyrazolo[1,2-a][1,2]diazepin-10-yl)-N4-o-tolylsuccinamide assessed as compound formation at 2 mM preincubated for 3 mins followed by NADPH addition measured after 1 hr in presence of GSH and [13C2-15N-glycine]-GSH by HPLC/MS method	Homo sapiens	8	ALA4043282	assay format	Scientific Literature
2.	ALA4048222	ADME	Drug level in rat liver microsomes treated with (R)-2-methyl-N1-((S)-11-oxo-1,2,3,5,10,11-hexahydrobenzo[d]pyrazolo[1,2-a][1,2]diazepin-10-yl)-N4-o-tolylsuccinamide assessed as compound formation at 2 mM preincubated for 3 mins followed by NADPH addition measured after 1 hr in presence of GSH and [13C2-15N-glycine]-GSH by HPLC/MS method	Rattus norvegicus	8	ALA4043282	assay format	Scientific Literature
3.	ALA4048223	ADME	Drug level in mouse liver microsomes treated with (R)-2-methyl-N1-((S)-11-oxo-1,2,3,5,10,11-hexahydrobenzo[d]pyrazolo[1,2-a][1,2]diazepin-10-yl)-N4-o-tolylsuccinamide assessed as compound formation at 2 mM preincubated for 3 mins followed by NADPH addition measured after 1 hr in presence of GSH and [13C2-15N-glycine]-GSH by HPLC/MS method	Mus musculus	8	ALA4043282	assay format	Scientific Literature